August 3, 2012
Thomas Triomphe, President, Sanofi Pasteur K.K. Thomas Triomphe, president of Sanofi Pasteur K.K., said on August 2 that the company is not planning to cut the price of its stand-alone inactivated polio vaccine (IPV) Imovax Polio SC Injection, against a...read more